In Aug, we added 124 citations in DIDB, including 69 in vitro (with 23 articles published in August 2025) and 55 in vivo articles (with 29 articles published in August 2025).
3 NDAs approved in July 2025, including delgocitinib (ANZUPGO), sunvozertinib (ZEGFROVY), and sepiapterin (SEPHIENCE) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.